30.06. – 01.07.2026 | Antibody industrial symposium
Montpellier / France
Montpellier / France
San Diego / USA
Berlin / Germany
London / UK
Boston, MA / USA
Specificity is key to developing safe TCR or TCR-like antibody therapeutics. YUMAB’S novel CHO-display library presents the natural human pHLA repertoire on the cell surface,
While conventional combinatorial libraries remain highly effective for a wide range of targets and offer significant diversity, paired antibody libraries enable the discovery of more
Conventional IgG antibodies are powerful tools for many applications. Despite their flexibility, they also encounter limits of feasibility. With their size of 150 kDa they
YUMAB and InSCREENeX are developing an innovative „Mammalian Display“ screening platform to accelerate antibody development. Braunschweig, January 29th, 2025 – YUMAB GmbH, a German biotechnology
Rare antibodies with unusual structures and ultra-long CDRs have the potential to bind to difficult-to-access epitopes (e.g., GPCRs, ion channels), and thus offer a unique